Health conditions

HIV and AIDS has become a major public health problem in many countries and monitoring the course of the epidemic and impact of interventions is crucial. Both the Sustainable Development Goals (SDGs) and the 2021 United Nations Political Declaration have set goals of reducing new HIV infections.

Number of people who acquired HIV during the reporting period

• Gender (female, male, other*)

• Age (0-14, 10–19, 15+,15–24,15–49, 50+ years)

• Key populations (men who have sex with men, people living in prisons, people who inject drugs, sex workers, trans and gender diverse people)

• Cities and other administrative regions of epidemiologic importance

*The category of other includes trans and gender diverse people who choose an identity other than male or female.

Methods for monitoring incidence can vary depending on the epidemic setting and are typically categorized either as direct or indirect measures. Direct measurement at a population level is preferred but can often be difficult to obtain. As a result, most if not all countries rely on indirect measures or triangulate direct and indirect methods.

Strategies for directly measuring HIV incidence include longitudinal follow-up and repeat testing among individuals who do not have HIV infection and estimation using a laboratory test for recent HIV infection and clinical data in the population. Longitudinal monitoring is often costly and difficult to perform at a population level. Laboratory testing of individuals to determine the recency of infection also raises cost and complexity challenges since a nationally representative population-based survey is typically required to obtain estimates.

Indirect methods most frequently rely on estimates constructed from mathematical modelling tools, such as Spectrum or the AIDS Epidemic Model. These models may incorporate geographical and population-specific HIV surveys, surveillance, case reporting, mortality, programme and clinical data and, in some instances, assumptions about risk behaviour and HIV transmission. In some instances, countries may wish to triangulate these data with other sources of estimates of the number of people newly infected, including from serial population-based HIV prevalence estimates or estimates of HIV prevalence in young, recently exposed populations.

Note that case-based surveillance systems capturing newly reported people acquiring HIV infection should not be used as a direct source of estimating the number of people newly infected with HIV in the reporting year. Because of reporting delays and underdiagnosis, newly reported cases may not reflect the actual rate of people becoming newly infected. This information may be useful, however, for triangulation or validation purposes, especially when combined with tests for the recency of HIV infection.

Disaggregated data reported for the numerator should be used to monitor progress towards eliminating new child infections and reducing the number of new HIV infections among adolescent girls and young women to below 100 000 per year.

Impact

Modelling, using multiple inputs specific to the HIV epidemic context, is typically used to obtain an estimate of the HIV prevalence rate. UNAIDS and WHO support most countries to produce estimates of HIV incidence annually using Spectrum.

Cases

Annual

Annual

beusenbergm@who.int

Michel Beusenberg

4659